58 results
8-K
EX-99.1
NMRD
Nemaura Medical Inc
14 Aug 23
Nemaura Medical Reports Fiscal First Quarter 2024 Results and Provides Business Update
8:30am
of these pilots. The data is expected to support reimbursement applications and product marketing in various territories.
Continued development of its … for reimbursement of sensors in the UK.
Continues to attract funding on favourable terms, and as a subsequent event the Company noted that it had secured
8-K
EX-99.1
NMRD
Nemaura Medical Inc
11 May 20
Nemaura reports positive data from early head-to-head comparison with a major incumbent CGM Device
3:43pm
developed as a viable, flexible, and cost-effective alternative to invasive continuous glucose monitors (“CGM”), and the company plans to seek reimbursement … people that are pre-diabetic and over 24 million people who have Type 2 diabetes in the US. Nemaura is intending to pursue reimbursement from
10-K
2015 FY
NMRD
Nemaura Medical Inc
23 Jun 15
Annual report
12:00am
and Wales and the EU
Healthcare Reimbursement
Government and private sector initiatives to limit the growth of healthcare costs, including price … of reimbursement they will pay for particular procedures or treatments. This has created an increasing level of price sensitivity among customers for products
8-K
EX-99.1
oh7kg9 ha
28 Sep 21
Regulation FD Disclosure
4:10pm
424B8
7isvro
11 Sep 23
Prospectus unintentially filed late
4:41pm
424B4
icvky7rf5yb25ymjt
15 May 23
Prospectus supplement with pricing info
4:31pm
424B3
ca339pasa229k
17 Nov 14
Prospectus supplement
12:00am
8-K
EX-99.1
pzzjl 1heb21gm95j7
11 Aug 23
Nemaura Medical Secures $6.5m in Non-Dilutive Funding
5:07pm
POS AM
b3yq3gatx9012n
3 Aug 23
Prospectus update (post-effective amendment)
4:08pm